1. Home
  2. SCOR vs IGC Comparison

SCOR vs IGC Comparison

Compare SCOR & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$4.85

Market Cap

73.5M

ML Signal

N/A

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

N/A

Current Price

$0.28

Market Cap

32.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCOR
IGC
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
32.0M
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
SCOR
IGC
Price
$4.85
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $5.25
AVG Volume (30 Days)
33.9K
★ 505.2K
Earning Date
05-05-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 127.37
59.09
EPS
N/A
★ N/A
Revenue
★ $403,549,000.00
$1,271,000.00
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
$13.06
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 1.02
N/A
52 Week Low
$4.60
$0.24
52 Week High
$9.34
$0.45

Technical Indicators

Market Signals
Indicator
SCOR
IGC
Relative Strength Index (RSI) 39.92 52.14
Support Level $4.66 $0.27
Resistance Level $5.27 $0.31
Average True Range (ATR) 0.29 0.01
MACD 0.06 0.00
Stochastic Oscillator 37.10 64.85

Price Performance

Historical Comparison
SCOR
IGC

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: